Hazelnut
MUFA-rich tree nut that modestly lowers LDL and total cholesterol
Nutrition per serving 1 oz (28 g, ~21 hazelnuts)
- Sugars 1.2 g4%
- Fibre 2.7 g10%
- Other carbs 0.8 g3%
- Protein 4.2 g15%
- Fat 17 g61%
- Other 2.1 g8%
| Nutrient | Per serving | % daily value |
|---|---|---|
| Fiber | 2.7 g | 10% |
| Protein | 4.2 g | 8% |
| Vitamin E | 4.2 mg | 28% |
| Magnesium | 46 mg | 11% |
| Copper | 0.48 mg | 53% |
| Manganese | 1.7 mg | 75% |
| Zinc | 0.69 mg | 6% |
| Selenium | 0.67 µg | 1% |
| Phosphorus | 81 mg | 6% |
| Potassium | 190 mg | 4% |
| Iron | 1.3 mg | 7% |
| Calcium | 32 mg | 2% |
| Folate | 32 µg | 8% |
Composition data: USDA FoodData Central ↗
What is Hazelnut?
Hazelnut (Corylus avellana) is a nut or seed used for lowers ldl ('bad') and total cholesterol in controlled feeding trials. NutriDex grades the human evidence as Moderate. Hazelnuts have moderate, mostly lipid-focused human evidence. A 2016 Bayesian meta-analysis (Perna et al., Nutrients) pooling nine controlled studies (~425 participants, 29-69 g/day for 4-12 weeks) found hazelnut-enriched diets significantly lowered LDL and total cholesterol, with HDL and triglycerides essentially unchanged and no effect on body weight or BMI - reassuring given their calorie density. Direct trial data on hard outcomes (heart attacks, diabetes, death) are limited; most cardiovascular evidence comes from nuts as a group. In the PREDIMED randomized trial (NEJM 2018), a Mediterranean diet supplemented with mixed nuts (walnuts, almonds and hazelnuts) reduced major cardiovascular events versus a control diet. Large prospective cohorts (Aune et al., BMC Medicine 2016) link higher nut intake to lower cardiovascular and all-cause mortality, but these are observational and not hazelnut-specific. Bottom line: good RCT support for cholesterol-lowering; benefits on weight, glycemia, and mortality are inferred largely from broader nut research rather than hazelnut trials.